Study tests if mailed guides help Alzheimer's caregivers cut dangerous drugs
NCT ID NCT06368115
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 25 times
Summary
This study tested whether mailing educational materials to caregivers of people with Alzheimer's disease could reduce the use of potentially harmful medications like sedatives, antipsychotics, and strong anticholinergics. Over 11,000 patients and their caregivers from two large health plans took part. The goal was to see if simple, mailed information could spark conversations with doctors and lead to safer prescribing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UMass Chan Medical School
Worcester, Massachusetts, 01605, United States
Conditions
Explore the condition pages connected to this study.